Subsequent Events (Details) (USD $)
In Millions, unless otherwise specified |
12 Months Ended | 0 Months Ended | 12 Months Ended | 0 Months Ended | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2010
|
Dec. 31, 2009
|
Dec. 31, 2008
|
Feb. 22, 2011
|
Feb. 22, 2011
Issuance of Debt [Member]
|
Feb. 22, 2011
Issuance of Debt [Member]
2.05% Senior Notes Due 2014 [Member]
|
Feb. 22, 2011
Issuance of Debt [Member]
3.20% Senior Notes due 2016 [Member]
|
Feb. 22, 2011
Issuance of Debt [Member]
4.50% Senior Notes due 2021 [Member]
|
Dec. 31, 2010
Sale of Businesses [Member]
|
Dec. 31, 2009
Sale of Businesses [Member]
|
Dec. 31, 2008
Sale of Businesses [Member]
|
Apr. 04, 2011
Sale of Businesses [Member]
Lancaster Laboratories [Member]
|
Apr. 04, 2011
Sale of Businesses [Member]
Athena Diagnostics [Member]
|
|
Sale of Businesses [Abstract] | |||||||||||||
Proceeds from sale of businesses, net of cash divested | $ 0 | $ 4.4 | $ 3.5 | $ 180.0 | $ 740.0 | ||||||||
Escrowed Proceeds From Sale of Business | 20.0 | ||||||||||||
Revenues | 226.2 | 205.3 | 190.5 | ||||||||||
Pre-tax Income | 58.9 | 46.6 | 35.1 | ||||||||||
Other Current Assets | 64.8 | 54.6 | |||||||||||
Other Assets | 451.0 | 468.5 | |||||||||||
Other Accrued Expenses | 17.6 | 16.5 | |||||||||||
Other Long-term Liabilities | 58.4 | 62.8 | |||||||||||
Issuance of Debt [Abstract] | |||||||||||||
Face Amount Issued | 2,200.0 | 300.0 | 900.0 | 1,000.0 | |||||||||
Debt Instrument, Interest Rate, Stated Percentage | 2.05% | 3.20% | 4.50% | ||||||||||
Notional Amount of Interest Rate Swap | $ 300 | ||||||||||||
Interest Rate Swap, Description Of Variable Rate Basis | six-month USD LIBOR | ||||||||||||
Interest Rate Swap, Basis Spread On Variable Rate | 0.4112% | ||||||||||||
Interest Rate Swap, Variable Interest Rate | 0.88% | ||||||||||||
Interest Rate Swap, Fixed Interest Rate | 2.05% | ||||||||||||
Debt Subject To Mandatory Redemption, Redemption Price | 101.00% |